Advocacy Feature image
ePolicy 300x175
eAdvocacy Center 300x175
  • news-thumbnail

    ePolicy News January 2015

    January 12, 2015
    FDA LDT Proposal Under the Microscope
    The controversy over the regulation of laboratory developed tests (LDTs) heated up this month in a public forum organized by the Food and Drug Administration (FDA) to discuss its proposal for a risk-based approach to regulate these assays. The Agency’s issuance last fall of a proposed framework for the regulation of LDTs signaled the end of the FDA's long-standing policy of "enforcement discretion." Read more
  • news-thumbnail

    ePolicy News December 2014

    December 08, 2014
    ASCP Urges Members to Contact Congress to Repeal the SGR before the New Year
    Please Access Our Action Alert Below and Send a Letter to Congress On This Important Issue! Read more
  • news-thumbnail

    ePolicy News November 2014

    November 06, 2014
    CMS Releases Outpatient Hospital and Physician Fee Schedule Final Rules
    Despite Several Advocacy Wins this Year, CMS Continues Its Misguided Quest to Reel in Overutilization via Payment Bundle Schemes at the Expense of Physicians and Labs Read more
  • news-thumbnail

    ePolicy News October 2014

    September 29, 2014
    House Subcommittee Examines FDA’s Plan to Regulate LDTs
    Last month, the House Energy and Commerce Health Subcommittee held a hearing to learn more about the highly anticipated guidance outlining the plan by the Food and Drug Administration (FDA) to regulate laboratory developed tests (LDTs). In July, the FDA notified Congress of its intent to issue two draft guidance documents regarding the oversight of LDTs. Read more

~/Custom.Templates/AdvocacyLanding.aspx